| | Your missing links are hereTop Picks Clinical Trials - New CRISPR clinical trial posted. A clinical trial on advanced hepatocellular carcinoma from Central South University in China using PD-1 knockout engineered T cells.
- Gene-edited T cells to treat diabetes inch closer to clinical trials. Researchers edit the genes of patients' T cells to turn off the destructive autoimmune response in Type 1 diabetes. Another approach using CRISPR-Cas9 was recently described.
COVID19 Industry Research Safety Vision and opinion Heh, huh, wow AI and CRISPR - the future is here! Israeli CRISPR-IL consortium to develop advanced tools for better efficiency and accuracy in genome editing of plants, animals and humans. Among the wide variety of companies is TargetGene, whose gene-editing platform TGEE we wrote about here.
| | |
| | Thank You for now. And if you have questions or suggestions, you can directly reach us at editor@crisprmedicinenews.com. We love hearing from readers! (c; Rasmus You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here. | | |
|
|